New Paradigms for Cytoreductive Nephrectomy

SIMPLE SUMMARY: Cytoreductive surgery (CS) is performed to remove the primary tumor in the setting of metastatic disease. In metastatic renal cell carcinoma (mRCC), the role of cytoreductive nephrectomy (CN) in the treatment paradigm has evolved, adjusting to new changes in systemic therapy agents....

Descripción completa

Detalles Bibliográficos
Autores principales: Lichtbroun, Benjamin J., Srivastava, Arnav, Doppalapudi, Sai Krishnaraya, Chua, Kevin, Singer, Eric A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179532/
https://www.ncbi.nlm.nih.gov/pubmed/35681638
http://dx.doi.org/10.3390/cancers14112660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179532/
https://www.ncbi.nlm.nih.gov/pubmed/35681638
http://dx.doi.org/10.3390/cancers14112660

Ejemplares similares